1980
DOI: 10.1016/0016-5085(80)90155-9
|View full text |Cite
|
Sign up to set email alerts
|

Healing of perineal Crohn's disease with metronidazole

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
116
0
7

Year Published

2004
2004
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 372 publications
(124 citation statements)
references
References 20 publications
1
116
0
7
Order By: Relevance
“…Medical therapy has demonstrated limited efficacy with relapse after cessation of treatment. [22][23][24][25][26][27][28][29][30][31][32] Operative treatment has shown good results [33][34][35] but puts the patient at an increased risk for fecal incontinence.…”
Section: Discussionmentioning
confidence: 99%
“…Medical therapy has demonstrated limited efficacy with relapse after cessation of treatment. [22][23][24][25][26][27][28][29][30][31][32] Operative treatment has shown good results [33][34][35] but puts the patient at an increased risk for fecal incontinence.…”
Section: Discussionmentioning
confidence: 99%
“…Evidence on fistulous disease remains anecdotal and based on outcome analysis from small observational studies. 18,19 Metronidazole reduces the bacteroides content of the colon and has immunosuppressive effects, but its effects rapidly wear off when it is stopped. Brandt et al 18 treated 26 patients with perianal Crohn_s disease with 20 mg/kg metronidazole daily; 10 patients progressed to complete healing and the remainder had partial healing.…”
Section: Medical Optionsmentioning
confidence: 99%
“…1 Spontaneous healing has been reported by Alexander-Williams and Buchmann. 2 Small or uncontrolled trials reported healing of up to 83 percent with medical treatments, including metronidazole, 3 azathioprine, 4 and 6-mercaptopurine. 5 However, fistula recurrence rate has been shown to be high after treatment was stopped.…”
mentioning
confidence: 99%
“…5 However, fistula recurrence rate has been shown to be high after treatment was stopped. 3 Surgical approaches include conventional fistulotomy, long-term seton drainage, and various advancement flap repairs. In recent years, infliximab, an IgG1 murine-human chimeric monoclonal antibody to tumor necrosis factor (TNF)-alpha, has been reported to close 46 percent of fistula in Crohn's disease.…”
mentioning
confidence: 99%